Tongrentang transformed into medicine plate behind the black horse. Entered 2011, last year of three Daniel unit Yunnan baiyao (000538, unit 's), and Dong-e e-Donkey-hide gelatin (000423, unit 's) and tablets Tsai 构词成分。 are appears substantially adjustment, but also is Chinese medicine enterprise, tongrentang is inverse city rise, Lunar Spring Festival zhihou gains more is obvious, from on February 9 to March 17, tongrentang from 30.65 Yuan highest rose to has 40.98 Yuan, highest gains reached has 34%, recently although has callback, but shares still in 37 Yuan above, gains still over 20%.
Recommended reading · fengji instant investment value ranking
· users real disk PK star Fund annual report display Fund tight at inflation Central Bank first to "in-depth" promoting small QFII pilot new Fund method try solutions two disaster institutions arbitrage played tricks ETF was huge redemption private equity hedge provisional no door easy party up Department three Fund together increased warehouse China heavy steam [hexun know] will cast 1000 Yuan suitable did and tongrentang 2010 annual report display, its Qian ten circulation shareholders in the has five I was Fund take, remaining seats also was insurance, and annuity, occupy.
What happened to the Tong ren Tang?
the "despise" century-old shop tongrentang has and its position in traditional Chinese medicine does not match the value.
Tong ren Tang was founded in 1669 and has already more than 300 years of history, Tong ren Tang, exclusive to the brand basis of variety and pharmaceutical technology can not be copied, in the field of traditional Chinese medicine has representative status not to be shaken.
On but these are not reflected in the valuation, on the a-share markets, to analogy with tongrentang only Yunnan baiyao and Dong-e e-Jiao, as of March 25, Yunnan baiyao and donge ejiao the market value of $ 38.99 billion and $ respectively, Tong ren Tang, only $ 19.45 billion.
And many investors in the industry's investment in tongrentang's current value is not recognized. "Now investment territories for tongrentang Basic has two points consensus, first, tongrentang is a is good of brand, they of products quality also is good, products also is has competitiveness; second, but tongrentang in strategy Shang, in management Shang, in marketing Shang also has is large of improved space, from now of situation see, also see does not out company in these aspects has substantive improved, so tongrentang of shares performance in medicine industry within long-term partial low, company of unique advantage and no get Premium.
"Bo Rui Deputy General Manager Zhang Shao-ping think of blue-chip investment management limited.
Although tongrentang in most of the Group's direct sales stores its major shareholder China Beijing tongrentang (Group) limited liability companies, but Zhang Shaoping believes that as the tongrentang between parent companies and subsidiaries of listed companies with a lot of related party transactions, therefore can be seen from the Tong ren Tang store operations of tongrentang whole management level, and from which you can analyze the cause of tongrentang low gross margin has been.
Tong ren Tang with the gross profit margin, the level of its prices and completely unable to match the unique advantages of the product. Product diversification in Yunnan baiyao 2010 report shows its main business of the year gross profit margin is also close to 30%, some exclusive Chinese medicine higher gross margins, Dong-e e-Jiao Jiao product gross profit margin close to 70%, owned by pientzehuang pientzehuang product gross profit margin is as high as 76%.
Tongrentang 2010 report shows, however, its main business gross margin was only 13.75%. Zhang Shao-ping has many stores for grassroots research to tongrentang. In the view of Zhang, Tong ren Tang store there a clear policy failures, "Tong ren Tang has established thousands of its own Terminal stores throughout the country, on the store location, tongrentang have chosen large shopping centres and commercial lots of very good, this site will have to be very high rents, in addition, Tong ren Tang decoration is also seeking to classical and luxury, which increased the store set up and operating costs.
"Swallowed by high start-up and operating costs of the tongrentang profits. "Tong ren Tang store is mainly to provide Chinese medicine products, the business profits are very slim, unlike proprietary Chinese medicines of traditional Chinese medicine or Western medicine, traditional Chinese medicine or Western medicine after refining, extraction, the final price can be very high, because consumers can't identify and compare, but if the rise in price of Chinese traditional medicine, consumers can easily perceive. But since last year, the price has gone up a lot of traditional Chinese medicine, traditional Chinese medicine sales that would squeeze profit margins. In addition to sales of traditional Chinese medicine, tongrentang stores also sell angong niuhuang pill of own products such as white wind, black chicken balls, but tongrentang's own products though, cannot support an own store sales, to address high costs such as rent, tongrentang select Maori and category sales amount larger ginseng tonic.
"Zhang Shaoping said. Shanghai, a private equity fund manager that "Although the sales of the tonic to keep ren Tang store matches, but ren Tang sales are only rough processing products such as ginseng, that is, raw materials and simple packaging of tongrentang, or directly sell other brands of tonic. Tonic with other specialty chains such as East, Wai Yuen Tong, Tong ren Tang has no advantage in this, even in lines, packaging and marketing practices are at a disadvantage. For consumers, whether it was purchased in tongrentang have purchased elsewhere, price is only associated with level of product quality, with little correlation between brand, that is, the products above, tongrentang's brand value did not play. "Even so, Shenzhen a private equity manager think from investment angle see, does not necessarily is bad, this are description tongrentang in cost control Shang also has is large of space, for tongrentang,, for example compression Terminal stores of number, to in each city established small flagship shop, increased related of products service, while by other sales channel to sales own of low value Chinese medicine products, while to reached publicity tongrentang of high-end brand image, on the also can save large cost expenditures.
Market investors are now looking at tongrentang's management, waiting for them. 3 behind high to match the 22nd, tongrentang released 2010 annual report, according to the annual report, achieving revenues during the reporting period 38.24Million, net profit of 343 million Yuan, up growth and 16.3%, respectively, basic earnings per share $ 0.659, an increase of 19.17%.
Which shows the growth of tongrentang remains General, but at the same time announced for profit distribution plan make people's eyes light up, Tong ren Tang said, proposed to send 10 Red Unit 5 shares were $ 3.5, while intended to be all the shareholders capital Provident Fund converted into share capital, each 10 converted into 10 units, this is the most generous dividends since tongrentang listed. "High to match is a subject of speculation in the market, this may be a driver of shares rose in early, but otherwise, higher sending the distribution itself revealed the positive signals worth looking forward to. "Shenzhen private persons above that" This shows the attention paid to the management of listed companies market presence. "These people told reporters, tongrentang high to match actually confirms a rumor that" tongrentang recent share price performance as market rumours the Government hoped in Beijing Tong ren Tang has also changed, if the rumors are true, you can expect enthusiasm in the management of the future will be mobilized, the company will fully reflect the value of out. "Rumor is probably not groundless, Tong ren Tang in the annual report made it clear that" 2010 Beijing tongrentang group as municipal party Committee and Government capital development leader in the pharmaceutical industry, overall access to biomedical "G20" engineering. State administration of traditional Chinese medicine, and other government sector development placed great hopes in tongrentang, national intent for Han and tongrentang group signed a strategic cooperation, to promote the culture of traditional Chinese medicine in the world-wide dissemination. Company as one of the core enterprise of tongrentang, will benefit from these initiatives, tongrentang group established by the overall strategic planning, will also help stimulate and promote the future development of the company. "Above private persons think, if management layer actively as, tongrentang future will has is strong of explosive force," will tongrentang and other Chinese medicine Enterprise for transverse comparison, can found, in recent years tongrentang almost is stop does not Qian, but other listed company are in for fast expansion, as Yunnan baiyao on stepped up new products development, around with own unique of products advantage for diversified, development out has Yunnan baiyao toothpaste, products, Dong-e e-Donkey-hide gelatin is big rubber block business, while pursuant to own unique of products advantage, take similar Guizhou maotai (600,519, unit 's) of price policy, to upgrade company profit ability, ConMed drug industry is focus on Shang downstream integration of construction, to gets more strong of competition advantage. "But" whether Yunnan baiyao, donge ejiao is ConMed pharmaceutical industry go the way of, Tong ren Tang who is easy to copy.
" asset injection suspicion in addition to actively improve the management, capital markets coveted the tongrentang assets in the hands of large shareholder. "Tongrentang group has quite a few quality assets into listed company is not, tongrentang its main ginseng, cordyceps and other high-end tonic health pharmaceutical company Tong ren Tang has not been into listed company; tongrentang in listed company mainly including traditional Chinese medicine section, and commercial chain also has not been injected.
"These private told a press conference in Shenzhen. Tongrentang large shareholders in addition to the a-share listed companies under the Tongren Temple and outside Hong Kong-listed company tongrentang technology also has special health tonic for Tong ren Tang Chinese traditional medicine in health medicine and is responsible for procurement and sales subsidiaries, tongrentang technology in the a-share listed companies in Hong Kong listed companies.
In addition to the two listed companies, tongrentang best asset is in the hands of big shareholders tongrentang health pharmacy.
Report from sinolink securities disclosed that in 2009, tongrentang tongrentang Group revenue reached 10.2 billion to shareholders, including listed companies and the tongrentang health pharmaceutical industry contribution income and 32%, respectively; major shareholders tongrentang Group profits reached more than more than 800 million, listed companies and health pharmaceutical industry contribution to profit and 47%, respectively.
Tongrentang significant related party transactions between group companies is also strengthening expectations of the market for Tong ren Tang asset injection. "Judging from the business structure, the group mainly by the pharmaceutical industry, pharmaceutical business and medical service consists of three blocks, while the three business segments at the level of legal entities and cross each other, business architecture group as a whole is not very clear, necessary for future integration.
"Sinolink securities research report. In addition, sinolink securities that "due to business and corporate units cross each other, leading Group AG as a listed company and other affiliated legal entities there are a lot of competition and correlation trading. From the perspective of supervision of listed companies, there are also necessary the integration of future. ”